GLYPRESSIN
Brand-level analytics aggregated across all owners and jurisdictions using this name.
Total filings
7
Live
5
Live %
71.4%
Distinct owners
2
Jurisdictions
7
Top NICE
5Pharmaceuticals
Owners Using This Brand Name
| # | Owner | Country | Filings |
|---|---|---|---|
| 1 | Ferring B.V. | NL | 3 |
| 2 | FERRING B.V. | NL | 2 |
| 3 | 荷蘭商輝凌公司 | NL | 1 |
| 4 | Ferring B.V | NL | 1 |
Geographic Coverage
Filing presence across major commercial IP offices. Color intensity is a log scale of filing count -- darker = more filings. Gaps may indicate expansion opportunities or unprotected markets.
Madrid Protocol (WIPO)
Less
More·Log scale
4 covered · 34 gaps · 38 target jurisdictions
Targets are major commercial IP offices. Gaps may indicate expansion opportunities or unprotected risk.
US○
United States
—
JP○
Japan
—
GB○
United Kingdom
—
IT○
Italy
—
TW●
Taiwan
1
EM○
European Union (EUIPO)
—
CN○
China
—
KR○
South Korea
—
HK●
Hong Kong
1
IN○
India
—
CA○
Canada
—
AU○
Australia
—
NZ○
New Zealand
—
DE○
Germany
—
FR○
France
—
ES○
Spain
—
CH○
Switzerland
—
NL○
Netherlands
—
BX○
Benelux
—
SE○
Sweden
—
NO○
Norway
—
PL○
Poland
—
TR○
Turkey
—
RU○
Russia
—
BR○
Brazil
—
MX○
Mexico
—
AR○
Argentina
—
AE○
United Arab Emirates
—
SA○
Saudi Arabia
—
IL●
Israel
1
ZA○
South Africa
—
SG●
Singapore
1· 0 live
MY○
Malaysia
—
TH○
Thailand
—
ID○
Indonesia
—
PH○
Philippines
—
VN○
Vietnam
—
WO○
Madrid (WIPO)
—
By Jurisdiction
| Jurisdiction | Total | Live |
|---|---|---|
| IL | 1 | 1 |
| HK | 1 | 1 |
| CL | 1 | 0 |
| TW | 1 | 1 |
| MM | 1 | 1 |
| SG | 1 | 0 |
| TT | 1 | 1 |
Recent Filings
| Date | Owner | Status | NICE | App # |
|---|---|---|---|---|
| 2023-04-26 | Registered | 5 | MM/T/2021/009326 | |
| 2014-10-30 | Abandoned | 5 | 1129734 | |
| 2013-07-12 | Registered | 5 | TT/M/1/047092 | |
| 1994-11-28 | Registered | 5 | 95777 | |
| 1992-05-07 | Registered | — | 081021962 | |
| 1992-03-18 | Cancelled | 5 | T9201916F | |
| — | Registered | 5 | 199406209 |